Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7022e391363a3cf3486bf3859ce0a7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 |
filingDate |
2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a53ede50da61d48b8dbf56c5b0fc02d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bef6f903eb3c1c61b2aaefd24df0e9 |
publicationDate |
2001-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1106611-A1 |
titleOfInvention |
Crystalline or crystallized acid addition salt of losartan and purification method of losartan |
abstract |
The present invention provides a crystalline or crystallized acid addition salt of Losartan useful for obtaining highly pure 2-n-butyl-4-chloro-1-ÄÄ2'-(1H-tetrazol-5-yl)Ä1,1'-biphenylÜ-4-ylÜmethy lÜ-1H-imidazole-5-methanol (Losartan), and a purification method of Losartan that includes production of the crystalline or crystallized acid addition salt. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066997-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066997-A2 |
priorityDate |
1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |